abstract |
Disclosed are a preparation and use of a novel kinase inhibitor. Specifically, provided is a compound of formula I, wherein the definition of each group is as defined in the specification. The compound of the present invention has good FGFR kinase inhibitory activity, and can be used to prepare a series of drugs for treating diseases related to the FGFR kinase activity. |